Drug
Astx727
Astx727: highest development phase Phase 1/2, developed by Incyte. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| ASTX727 NCT04061421 | Phase 1/2 | MDS/MPN |
Latest
No recent events.
Follow Astx727 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.